The Virtual Brain links transcranial magnetic stimulation evoked potentials and inhibitory neurotransmitter changes in major depressive disorder
Discuss this preprint
Start a discussion What are Sciety discussions?Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Background
Transcranial magnetic stimulation evoked potentials (TEPs) show promise as a biomarker in major depressive disorder (MDD), but the origin of the increased TEP amplitude in these patients remains unclear. Gamma aminobutyric acid (GABA) may be involved, as TEP peak amplitude is known to increase with GABAergic activity in healthy controls. We employed a computational modeling approach to investigate this phenomenon.
Methods
Whole-brain simulations in ‘The Virtual Brain’ ( thevirtualbrain.org ), employing the Jansen and Rit neural mass model, were optimized to simulate TEPs of healthy individuals ( N subs =20, 14 females, 24.5±4.9 years). To mimic MDD-like impaired inhibition, a GABAergic deficit was introduced to the simulations by altering one of two selected inhibitory parameters, the inhibitory synaptic decay rate b or the number of inhibitory synapses C 4 . The TEP amplitude was quantified and compared for all simulations.
Results
The inhibitory synaptic decay rate showed a quadratic correlation (r=0.99, p<0.001) and the number of inhibitory synapses a negative exponential correlation (r=0.99, p<0.001) with the TEP amplitude. Moreover, significant correlations between these simulation-derived values and all TEP peaks and troughs were detected (p<0.001). Thus, under local parameter changes, we were able to alter the TEP amplitude towards pathological levels, i.e. creating an MDD-like increase of the global mean field amplitude in line with empirical results.
Conclusions
Our model suggests specific GABAergic deficits as the cause of increased TEP amplitude in MDD patients, which may serve as therapeutic targets. This work highlights the potential of whole-brain simulations in the investigation of neuropsychiatric diseases.
